Romiplate®/ Nplate®, a genetically recombinant protein, stimulates platelet production via stimulation of the thrombopoietin receptors. Chronic ITP is normally treated with pharmaceuticals that improve blood platelet count by suppressing platelet destruction, but Romiplate®/ Nplate®, serves to improve platelet counts by stimulating platelet production.
Marketed by Kyowa Hakko Kirin in
- Hong Kong( Chinese / English )
- Macau( Chinese / English )
- Taiwan( Chinese )
- Korea( Korean )
- Singapore( English )